Related Experiment Videos
Identification of multiple HIV-1 CTL epitopes presented by HLA-B*5101 molecules
H Tomiyama1, T Sakaguchi, K Miwa
1Division of Viral Immunology, Center for AIDS Research, Kumamoto University, Japan.
Human Immunology
|May 13, 1999
Summary
Researchers identified human immunodeficiency virus type 1 (HIV-1) cytotoxic T lymphocyte (CTL) epitopes presented by HLA-B51. These identified epitopes, particularly conserved ones, may be crucial for controlling HIV-1 infection.
Area of Science:
- Immunology
- Virology
- Genetics
Background:
- Human immunodeficiency virus type 1 (HIV-1) infection is a global health concern.
- HLA-B51 is associated with slower progression to acquired immunodeficiency syndrome (AIDS).
- Cytotoxic T lymphocytes (CTLs) play a critical role in controlling viral infections, including HIV-1.
Purpose of the Study:
- To identify and characterize HIV-1 CTL epitopes presented by the HLA-B51 allele.
- To investigate the potential role of these epitopes in immune response to HIV-1.
Main Methods:
- HLA-B*5101 stabilization assay was used to screen HIV-1 peptides.
- Peripheral blood mononuclear cells (PBMCs) from HIV-1 seropositive individuals carrying HLA-B51 were stimulated with binding peptides.
- Specific CTL clones were used to confirm the identified epitopes.
Main Results:
- 33 out of 172 screened HIV-1 peptides bound to HLA-B*5101.
- Seven peptides were suggested as potential HIV-1 CTL epitopes.
- Six of these seven peptides were confirmed as HLA-B*5101 presented epitopes.
- Three identified epitopes are highly conserved among HIV-1 clade B strains.
Conclusions:
- Identified HLA-B51-presented HIV-1 CTL epitopes are confirmed.
- Conserved epitopes presented by HLA-B51 may be important for controlling HIV-1 infection.
- These epitopes can be utilized for analyzing CTL responses in HIV-1 infected individuals.